A Local Retrospective Observational Study to Evaluate the Treatment Patterns of mCRPC Patients in Belgium Treated With Radium-223

A Local Retrospective Observational Study to Evaluate the Treatment Patterns of mCRPC Patients in Belgium Treated With Radium-223

The aim of this non interventional study is to describe the proportion of Belgian mCRPC patients which were treated with 1 to 4 and 5 to 6 Radium-223 injections and the patient characteristics which are potentially associated with this proportion.

Inclusion Criteria:

• Patients with a diagnosis of castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases
• All consecutive patients who started Radium-223 treatment between 22 December 2014 and 01 June 2017
• Availability of medical records during the observation period (22DEC2013 - 01JUN2018)

Exclusion Criteria:

• Patients treated with Radium-223 for any reason before 22 December 2014 (for example an interventional trial)
• Patients participated in an investigational program with interventions outside of routine clinical practice during the radium-223 treatment period
• Patients received other radiopharmaceuticals for the systemic concomitant use for treatment of prostate cancer or for other use during the Radium-223 treatment period